We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-15.79%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$16.4B
AUM Growth
+$4.51B
Cap. Flow
+$7.45B
Cap. Flow %
45.53%
Top 10 Hldgs %
3.04%
Holding
4,763
New
1,229
Increased
1,758
Reduced
1,274
Closed
428

Top Buys

Rank Stock Value
1
AXP icon
American Express
AXP
+$71M
2
BAC icon
Bank of America
BAC
+$53.3M
3
MPC icon
Marathon Petroleum
MPC
+$49.5M
4
ILMN icon
Illumina
ILMN
+$47.8M
5
NKE icon
Nike
NKE
+$44.9M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$43.1M
2
ZTS icon
Zoetis
ZTS
+$33.2M
3
CL icon
Colgate-Palmolive
CL
+$25.5M
4
QCOM icon
Qualcomm
QCOM
+$23.7M
5
FRC
First Republic Bank
FRC
+$23.1M

Sector Composition

Rank Sector Weight
1 Financials 15.38%
2 Technology 14.53%
3 Consumer Discretionary 10.24%
4 Healthcare 9.93%
5 Industrials 9.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHX
4376
DELISTED
ChampionX
CHX
-69,680
Closed -$1.71M
CKPT
4377
DELISTED
Checkpoint Therapeutics
CKPT
-9,381
Closed -$166K
CLDX icon
4378
Celldex Therapeutics
CLDX
$3.28B
-12,633
Closed -$430K
CLSD
4379
DELISTED
Clearside Biomedical
CLSD
-1,280
Closed -$44K
CNXN icon
4380
PC Connection
CNXN
$2.12B
-5,723
Closed -$300K
COHU icon
4381
Cohu
COHU
$2.5B
-21,115
Closed -$625K
COLL icon
4382
Collegium Pharmaceutical
COLL
$956M
-74,897
Closed -$1.52M
CRAI icon
4383
CRA International
CRAI
$1.06B
-4,046
Closed -$341K
CRDF icon
4384
Cardiff Oncology
CRDF
$77.2M
-69,090
Closed -$171K
CRGY icon
4385
Crescent Energy
CRGY
$3.82B
-30,143
Closed -$523K
CRVS icon
4386
Corvus Pharmaceuticals
CRVS
$1.17B
-6,600
Closed -$11K
CSAN icon
4387
Cosan
CSAN
$2.84B
-11,827
Closed -$234K
CSR
4388
Centerspace
CSR
$952M
-2,703
Closed -$265K
CTOS icon
4389
Custom Truck One Source
CTOS
$2.37B
-18,089
Closed -$152K
CTRE icon
4390
CareTrust REIT
CTRE
$9.74B
-67,433
Closed -$1.3M
CURV icon
4391
Torrid Holdings
CURV
$260M
-17,816
Closed -$108K
CVGW
4392
DELISTED
Calavo Growers
CVGW
-64,487
Closed -$2.35M
BGMS
4393
Bio Green Med Solution Inc
BGMS
$5.24M
0
CYRX icon
4394
CryoPort
CYRX
$762M
-73,141
Closed -$2.55M
DCGO icon
4395
DocGo
DCGO
$62.6M
-76,701
Closed -$709K
DFIN icon
4396
Donnelley Financial Solutions
DFIN
$1.16B
-28,287
Closed -$941K
DFH icon
4397
Dream Finders Homes
DFH
$1.36B
-57,629
Closed -$984K
DH icon
4398
Definitive Healthcare
DH
$75.3M
-83,906
Closed -$2.07M
DIN icon
4399
Dine Brands
DIN
$452M
-7,590
Closed -$592K
DMRC icon
4400
Digimarc Corp
DMRC
$178M
-10,036
Closed -$265K

Similar funds

Cubist Systematic Strategies's Q2 2022 Portfolio in Review

As of Q2 2022, Cubist Systematic Strategies held 4,763 positions worth $16.4B, up 38% from $11.8B the previous quarter. Its ten largest holdings account for 3% of the portfolio.

Cubist Systematic Strategies deployed $7.45B of net new capital in Q2 2022, opening 1,229 new positions and adding to 1,758 existing holdings. Its largest new stake was Sierra Lake Acquisition Corp. Class A Common Stock: 1,393,075 shares worth $13.8M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Verizon, an estimated $43.1M trimmed.

  • Cubist Systematic Strategies's largest Q2 2022 buy was Sierra Lake Acquisition Corp. Class A Common Stock: 1,393,075 shares worth $13.8M.
  • Cubist Systematic Strategies added most to American Express in Q2 2022, an estimated $71M increase.
  • Cubist Systematic Strategies's biggest Q2 2022 reduction was Verizon, cutting an estimated $43.1M.
  • Cubist Systematic Strategies fully exited UnitedHealth in Q2 2022, selling an estimated $17.1M.
  • Cubist Systematic Strategies's ten largest holdings make up 3% of its $16.4B portfolio in Q2 2022.
  • Cubist Systematic Strategies opened 1,229 new positions and closed 428 in Q2 2022.
  • Cubist Systematic Strategies's portfolio value rose 38% quarter-over-quarter to $16.4B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.